Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03703050 |
Title | Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) (NIVO-ALCL) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Gustave Roussy, Cancer Campus, Grand Paris |
Indications | |
Therapies | |
Age Groups: | adult | child | senior |
Covered Countries | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Rigshospitalet | Recruiting | Copenhagen | Denmark | Details | ||
Gustave Roussy | Recruiting | Villejuif | Val De Marne | 94805 | France | Details |
CHU Bordeaux Hopital Pellegrin | Recruiting | Bordeaux | 33076 | France | Details | |
Centre Léon Berard Lyon | Recruiting | Lyon | 69008 | France | Details | |
Hopital Saint Louis | Withdrawn | Paris | 75010 | France | Details | |
CHU Toulouse Hopital des enfants | Recruiting | Toulouse | 31059 | France | Details | |
IUC Toulouse | Recruiting | Toulouse | 31059 | France | Details | |
CHU de nancy | Recruiting | Vandœuvre-lès-Nancy | 54500 | France | Details | |
Princess Maxima center | Not yet recruiting | Utrecht | Netherlands | Details |